Biomarker changes that occur in the period between normal cognition and the diagnosis of sporadic Alzheimer’s disease have not been extensively investigated in longitudinal studies. We conducted a ...

CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study This study includes the PanCareSurFup and ProCardio cohort of ≥ 5 ...

Potentially life-threatening cutaneous adverse drug reactions (cADRs) are associated with commonly prescribed oral antibiotics, according to a large, population-based, nested case-control study of ...

In middle-aged and older adults with overactive bladder, the drug selected for treatment may influence the risk for dementia. Investigators conducted a nested case-control study using data from ...

The July 20, 2023, article by Reulen et al entitled “Risk Factors for Primary Bone Cancer After Childhood Cancer: A PanCare Childhood and Adolescent Cancer Survivor ...